scholarly article | Q13442814 |
P2093 | author name string | Yufeng Li | |
Ping Jiang | |||
Jianjun Dai | |||
Jing Qi | |||
Yijun Du | |||
Congzhi Li | |||
Shuyi Duan | |||
P2860 | cites work | Foot-and-mouth disease virus: biology and prospects for disease control | Q34935334 |
Molecular basis of pathogenesis of FMDV. | Q35044850 | ||
FMD vaccines | Q35044859 | ||
New approaches to vaccination against foot-and-mouth disease | Q35237121 | ||
Developments in foot-and-mouth disease vaccines | Q36395476 | ||
Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins | Q37742938 | ||
Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease | Q39699303 | ||
Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99. | Q40433851 | ||
Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris. | Q40452590 | ||
An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine | Q40533709 | ||
Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. | Q40616705 | ||
Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure | Q40857755 | ||
Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate | Q40920483 | ||
Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice | Q42800320 | ||
Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. | Q44550766 | ||
Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus | Q45415581 | ||
Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. | Q45419096 | ||
Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus | Q45600695 | ||
Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus | Q45710581 | ||
The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cells | Q45730227 | ||
Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. | Q45733658 | ||
Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein | Q45734367 | ||
Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus | Q45743836 | ||
Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. | Q45750862 | ||
Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice | Q45855274 | ||
Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus | Q45860075 | ||
Expressions of Bovine IFN-gamma and foot-and-mouth disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens. | Q54646040 | ||
Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence | Q59068267 | ||
Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK | Q59097926 | ||
Biochemical characterization of FMDV A10 and A22 subtypes by PAGE and IEF | Q73045377 | ||
Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model | Q74334942 | ||
Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model | Q79329188 | ||
P433 | issue | 3-4 | |
P921 | main subject | foot-and-mouth disease | Q152401 |
Adenoviridae | Q193447 | ||
foot-and-mouth disease virus | Q1911079 | ||
P304 | page(s) | 274-283 | |
P577 | publication date | 2008-04-22 | |
P1433 | published in | Veterinary Immunology and Immunopathology | Q7923704 |
P1476 | title | Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs | |
P478 | volume | 124 |
Q42197160 | A Refined Guinea Pig Model of Foot-and-Mouth Disease Virus Infection for Assessing the Efficacy of Antiviral Compounds. |
Q45357895 | Co-administration of live attenuated Salmonella enterica serovar Typhimurium expressing swine interleukin-18 and interferon-α provides enhanced Th1-biased protective immunity against inactivated vaccine of pseudorabies virus |
Q64982394 | Effect of IL-2 co-expressed or co-inoculated with immuno-dominant epitopes from VP1 protein of FMD virus on immune responses in BALB/c mice. |
Q33761087 | Induction of protective immune response against both PPRV and FMDV by a novel recombinant PPRV expressing FMDV VP1. |
Q45375847 | Live attenuated Salmonella enterica serovar Typhimurium expressing swine interferon-alpha has antiviral activity and alleviates clinical signs induced by infection with transmissible gastroenteritis virus in piglets |
Q42188915 | Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine |
Q54377422 | Production of Recombinant Porcine Interferon alpha Using PHB–Intein-Mediated Protein Purification Strategy |
Search more.